Literature DB >> 15294991

The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii.

Nicolas Rachinel1, Dominique Buzoni-Gatel, Chaitali Dutta, Franck J D Mennechet, Souphalone Luangsay, Laurie A Minns, Michael E Grigg, Stanislas Tomavo, John C Boothroyd, Lloyd H Kasper.   

Abstract

The role of specific microbial Ags in the induction of experimental inflammatory bowel disease is poorly understood. Oral infection of susceptible C57BL/6 mice with Toxoplasma gondii results in a lethal ileitis within 7-9 days postinfection. An immunodominant Ag of T. gondii (surface Ag 1 (SAG1)) that induces a robust B and T cell-specific response has been identified and a SAG1-deficient parasite (Deltasag1) engineered. We investigated the ability of Deltasag1 parasite to induce a lethal intestinal inflammatory response in susceptible mice. C57BL/6 mice orally infected with Deltasag1 parasites failed to develop ileitis. In vitro, the mutant parasites replicate in both enterocytes and dendritic cells. In vivo, infection with the mutant parasites was associated with a decrease in the chemokine and cytokine production within several compartments of the gut-associated cell population. RAG-deficient (RAG1(-/-)) mice are resistant to the development of the ileitis after T. gondii infection. Adoptive transfer of Ag-specific CD4(+) effector T lymphocytes isolated from C57BL/6-infected mice into RAG(-/-) mice conferred susceptibility to the development of the intestinal disease. In contrast, CD4(+) effector T lymphocytes from mice infected with the mutant Deltasag1 strain failed to transfer the pathology. In addition, resistant mice (BALB/c) that fail to develop ileitis following oral infection with T. gondii were rendered susceptible following intranasal presensitization with the SAG1 protein. This process was associated with a shift toward a Th1 response. These findings demonstrate that a single Ag (SAG1) of T. gondii can elicit a lethal inflammatory process in this experimental model of pathogen-driven ileitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294991     DOI: 10.4049/jimmunol.173.4.2725

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality.

Authors:  J P Dubey; L R Ferreira; J Martins; Rima McLeod
Journal:  Parasitology       Date:  2011-11-14       Impact factor: 3.234

Review 2.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

3.  Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine.

Authors:  Seon-Kyeong Kim; Ariela Karasov; John C Boothroyd
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

4.  The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice.

Authors:  Elizabeth Charles; Michelle C Callegan; Ira J Blader
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

5.  Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1.

Authors:  Arunasalam Naguleswaran; Arsenio M Fialho; Anita Chaudhari; Chang Soo Hong; Ananda M Chakrabarty; William J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

Review 6.  Toxoplasma gondii: 25 years and 25 major advances for the field.

Authors:  John C Boothroyd
Journal:  Int J Parasitol       Date:  2009-07-01       Impact factor: 3.981

7.  Biological role of surface Toxoplasma gondii antigen in development of vaccine.

Authors:  Ke-Yi Liu; Dian-Bo Zhang; Qing-Kuan Wei; Jin Li; Gui-Ping Li; Jin-Zhi Yu
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

8.  Intraepithelial lymphocytes, goblet cells and VIP-IR submucosal neurons of jejunum rats infected with Toxoplasma gondii.

Authors:  Débora M G Sant'Ana; Marcelo B Góis; Jacqueline N Zanoni; Aristeu V da Silva; Cleverton J T da Silva; Eduardo J A Araújo
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

9.  The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis.

Authors:  Kevin M Brown; Ira J Blader
Journal:  J Ocul Biol Dis Infor       Date:  2009-12-12

10.  CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system.

Authors:  Luciana Benevides; Cristiane Maria Milanezi; Lucy Megumi Yamauchi; Cláudia Farias Benjamim; João Santana Silva; Neide Maria Silva
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.